Transplant International

, Volume 2, Issue 3, pp 147–164 | Cite as

Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation

  • W. J. van Son
  • T. H. The
Review Article

Abstract

Cytomegalovirus infections are still the most important infectious complications after organ transplantation. Besides historical notes this review will deal with new aspects concerning the epidemiology of the CMV, diagnostic modalities of CMV infection, the delicate counterbalance between the immune system and the CMV, as well as the symptomatology of this infection. Furthermore, aspects like prophylaxis and new, promising therapeutic regimes for treatment of infection will be dealt with. Although this update is applicable for all types of solid organ transplantation, emphasis will be on renal transplantation.

Key words

Kidney transplantation, cytomegalovirus infection Cytomegalovirus infection, in kidney transplantation Cytomegalovirus infection and rejection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ackermann JR, LeFor W, Weinstein S, Kahana L, Shires DL, Tardif G, Baxter J (1988) Four year experience with exclusive use of cytomegalovirus (CMV) Ah-negative donors for CMV-Ab-negative kidney recipients. Transplant Proc 20 [Suppl 1]: 469–471PubMedGoogle Scholar
  2. 2.
    Alford CA Jr, Britt WJ (1985) Cytomegalovirus. In: Fields BN (ed) Virology, Raven Press, New York, pp 629–660Google Scholar
  3. 3.
    Ayulo M, Aisner SC, Margolis K, Moravec C (1980) Cytomegalovirus-associated gastritis in a compromised host. JAMA 243: 1364PubMedCrossRefGoogle Scholar
  4. 4.
    Balfour HH Jr, Welo PK, Sachs GW (1985) Cytomegalovirus vaccine trial in 400 renal transplant candidates. Transplant Proc 17: 81–83Google Scholar
  5. 5.
    Balfour HH Jr, Chace BA, Stapleton JT, Simmons RL, Fryd DS (1989) A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381–1387PubMedCrossRefGoogle Scholar
  6. 6.
    Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I-antigens. Nature 331: 269–271PubMedCrossRefGoogle Scholar
  7. 7.
    Betts RF (1982) Cytomegalovirus infection in transplant patients. Prog Med Virol 28: 44–64PubMedGoogle Scholar
  8. 8.
    Betts RF, Schmidt SG (1981) Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans. J Infect Dis 143: 821–826PubMedGoogle Scholar
  9. 9.
    Betts RF, Freeman RB, Douglas RG, Talley TE, Rundell B (1975) Transmission of cytomegalovirus infection with renal allografts. Kidney Int 8: 385–392PubMedGoogle Scholar
  10. 10.
    Betts RF, Freeman RB, Douglas RG Jr, Talley TE (1977) Clinical manifestation of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 131: 759–763PubMedGoogle Scholar
  11. 11.
    Bia MJ, Andiman W, Gaudio K, Kliger A, Siegel N, Smith D, Flye W (1985) Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation 40: 610–614PubMedGoogle Scholar
  12. 12.
    Bij W van der, Dijk RB van, Son WJ van, Torensma R, Prenger KB, Prob JM, Tegzess AM, The TH (1988) Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients. J Heart Transplant 7: 106–110PubMedGoogle Scholar
  13. 13.
    Bij W van der, Torensma R, Son WJ van, Anema J, Schirm J, Tegzess AM, The TH (1988) Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 25: 179–188PubMedGoogle Scholar
  14. 14.
    Biron KK, Stanat SC, Sorrell JB, Fyfe JA, Keller PM, Lambe CU, Nelson DJ (1985) Metabolic activation of the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine in human diploid fibroblast infected with human cytomegalovirus. Proc Natl Acad Sci USA 82: 2473–2477PubMedGoogle Scholar
  15. 15.
    Biron KK, Fyfe JA, Stanat SC, Leslie KK, Sorrell JB, Lambe CU, Coen DM (1986) A human cytomegalovirus mutant resistant to the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine (BW B 759 U) induces reduced levels of BW B 759 U triphosphate. Proc Natl Acad Sci USA 83: 8769–8773PubMedGoogle Scholar
  16. 16.
    Black FL, Woodall JP, Evans AS, Liebhaber H, Henle G (1970) Prevalence of antibody against viruses in the Tiriyo, an isolated Amazon tribe. Am J Epidemiol 91: 430–438PubMedGoogle Scholar
  17. 17.
    Boyce NW, Hayes K, Gee D, Holdsworth SR, Thomson NM, Scott D, Atkins RC (1988) Cytomegalovirus infection complicating renal transplantation and its relationship to acute transplant glomerulopathy. Transplantation 45: 706–709PubMedGoogle Scholar
  18. 18.
    Brand A, Gratama JW (1985) CMV and blood transfusions. In: Meer JWM van der, Versteeg J (eds) Cytomegalovirus. Proceedings of postacademic course “Boerhaave”, Leyden, pp 65–74Google Scholar
  19. 19.
    Brando B, Civati G, Busnach G, Braggi ML, Belli LS, Seveso M, Brunati C, Minetti L (1985) Cytomegalovirus infection in cyclosporine A treated renal transplant recipients. Transplant Proc 17: 2683–2685Google Scholar
  20. 20.
    Braun WE, Nankervis G, Banowsky LH, Protiva D, Bückert E, McHenny MC (1976) A prospective study of cytomegalovirus infection in 75 renal allograft recipients. Proc Clin Dial Transplant Forum 6: 8–12PubMedGoogle Scholar
  21. 21.
    Broughton WL, Cupples HP, Parver LM (1978) Bilateral retinal detachment following cytomegalovirus retinitis. Arch Ophthalmol 96: 618–619PubMedGoogle Scholar
  22. 22.
    Bruning JH, Bruggeman CA, Boven CPA van, Breda Vriesman PJC van (1986) Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplantation 41: 695–698PubMedGoogle Scholar
  23. 23.
    Bruning JH, Bruggeman CA, Boven CPA van, Breda Vriesman PJC van (1989) Enhancement of reactivation of latent rat cytomegalovirus by combination of immunosuppression and administration of allogenic immunocompetent cells. Transplantation: 47: 742–744PubMedGoogle Scholar
  24. 24.
    Buhles WC Jr, Mastre BJ, Tinker AJ, Strand V, Koretz SH (1988) Ganciclovir treatment of life or sight-threatening cytomegalovirus infection. Experience in 314 immunocompromised patients. Rev Infect Dis 10 [Suppl 3]: 495–506Google Scholar
  25. 25.
    Cacoub P, Deray G, Baumelou A, Le Hoang P, Rozenbaum W, Gentilini M, Soubrie C, Rousselie F, Jacobs C (1988) Acute renal failure induced by foscarnet: 4 cases. Clin Nephrol 29: 315–318PubMedGoogle Scholar
  26. 26.
    Carney WP, Hirsch MS (1981) Mechanisms of immunosuppression in cytomegalovirus mononucleosis. J Infect Dis 144: 47–54PubMedGoogle Scholar
  27. 27.
    Chachoua A, Dieterich D, Krazinsky K, Greene J, Laubenstein L, Wernz J, Buhles W, Koretz S (1987) 9-(1,3-dihydroxy-2-propoxymethyl) guanine (ganciclovir) in the treatment of cytomegalovirus disease with the acquired immunodeficiency syndrome. Ann Intern Med 107: 133–137PubMedGoogle Scholar
  28. 28.
    Chalmer JE, Mackenzie JS, Stanley NF (1977) Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37: 107–114PubMedGoogle Scholar
  29. 29.
    Chatterjee SN, Jordan GN (1979) Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients. Transplantation 28:457–460PubMedGoogle Scholar
  30. 30.
    Cheeseman SH, Rubin RH, Stewart JA, Tolkoff-Rubin NE, Cosimi AB, Cantell K, Gilbert J, Winkle S, Herrin JT, Black PH, Russell PS, Hirsch M (1979) Controlled clinical trial of prophylactic human leukocyte interferon in renal transplantation: effects on cytomegalovirus and herpes simplex infection. N Engl J Med 300: 1345–1349PubMedCrossRefGoogle Scholar
  31. 31.
    Cheeseman SH, Stewart JA, Winkle S, Cosimi AB, Tolkoff-Rubin NE, Russell PS, Baker GP, Herrin J, Rubin RH (1979) Cytomegalovirus excretion 2–14 years after renal transplantation. Transplant Proc 11: 71–74PubMedGoogle Scholar
  32. 32.
    Ch'ien LT, Cannon NJ, Whitley RJ, Diethelm AG, Dismukes WE, Scott CW, Buchanan RA, Alford CA Jr (1974) Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis 130: 32–39PubMedGoogle Scholar
  33. 33.
    Chou S (1986) Acquisition of donor strains of cytomegalovirus by renal transplant recipients. N Engl J Med 314: 1418–1423PubMedCrossRefGoogle Scholar
  34. 34.
    Chou S, Merigan TC (1983) Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridization. N Engl J Med 308: 921–925.PubMedCrossRefGoogle Scholar
  35. 35.
    Chou S, Norman DJ (1985) Effects of OKT3 antibody therapy on cytomegalovirus reactivation in renal transplant recipients. Transplant Proc 17: 2755–2756Google Scholar
  36. 36.
    Chung A, Chang W, Leung MK, Ofosu FA, Moore BPL (1984) Assessment of methods for cytomegalovirus antibody testing of blood donation. Vox Sang 47: 343–347PubMedGoogle Scholar
  37. 37.
    Clarke J, Craig RM, Saffro R, Murphy P, Yokoo H (1979) Cytomegalovirus granulomatous hepatitis. Am J Med 66: 264–269PubMedCrossRefGoogle Scholar
  38. 38.
    Cohen EB, Komorowski RA, Kauffman HM, Adams M (1985) Unexpectedly high incidence of cytomegalovirus infection in apparent peptic ulcers in renal transplant patients. Surgery 97: 606–612PubMedGoogle Scholar
  39. 39.
    Collaborative DHPG Treatment Study Group (1986) Treatment of serious cytomegalovirus infections with 9(1,3-dihydroxy-2-ropoxymethyl)guanine in patients with AIDS and other immunodeficiencies. N Engl J Med 314: 801–805CrossRefGoogle Scholar
  40. 40.
    Condie RM, O'Reilly RJ (1984) Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native unmodified cytomegalovirus globulin. Randomized trial in bone-marrow transplant recipients. Am J Med 76: 134–141PubMedCrossRefGoogle Scholar
  41. 41.
    Cooper NR (1988) Complement-dependent neutralization of viruses. In: Rother K, Till GO (eds) The complement system, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo, pp 342–348Google Scholar
  42. 42.
    Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG (1988) Rapid detection of cytomegalovirus pulmonary infection by broncho-alveolar lavage and centrifugation culture. Ann Intern Med 108: 180–185PubMedGoogle Scholar
  43. 43.
    Crumpacker C, Marlow S, Zhang JL, Abrams S, Watkins P (1988) Treatment of cytomegalovirus pneumonia. Rev Infect Dis 10 [Suppl 3]: 538–546Google Scholar
  44. 44.
    Daniele RP (1981) Immune-complex injury of the lung. Am Rev Respir Dis 124: 738–755PubMedGoogle Scholar
  45. 45.
    Diosi P, Arean P, Plavosin L (1974) Genetic control of resistance to mouse cytomegalovirus infection. Arch Geschwulstforsch 44: 23–27CrossRefGoogle Scholar
  46. 46.
    Dorfman LJ (1973) Cytomegalovirus encephalitis in adults. Neurology 23: 136–144PubMedGoogle Scholar
  47. 47.
    Dorp W van, Jonges E, Bruggeman CA, Daha MR, Es LA van, Woude FJ van der (1989) Cytomegalovirus infection directly induces MHC class I but not class II expression on endothelial cells. Transplantation (in press)Google Scholar
  48. 48.
    Dowling JN, Saslow AR, Armstrong JA, Ho M (1976) Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders. J Infect Dis 133: 399–408PubMedGoogle Scholar
  49. 49.
    Dowling JN, Wu BC, Armstrong JA, Ho M (1977) Enhancement of murine cytomegalovirus infection during graft-versus-host-reaction. J Infect Dis 135: 990–994PubMedGoogle Scholar
  50. 50.
    Drew WL (1988) Diagnosis of cytomegalovirus infection. Rev Infect Dis 10 [Suppl 3]: 468–476Google Scholar
  51. 51.
    Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH (1987) Ganciclovir treatment of cytomegalovirus-disease in transplant recipients and other immunocompromised hosts. JAMA 257: 3082–3087PubMedCrossRefGoogle Scholar
  52. 52.
    Erice A, Chou S, Biron KK, Stanat SC, Balfour HH, Jordan MC (1989) Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med 320: 289–293PubMedCrossRefGoogle Scholar
  53. 53.
    Es A van, Baldwin WM, Oljans PJ, Tanke HJ, Ploem JS, Es LA van (1984) Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft rejection episodes and cytomegalovirus infection. Transplantation 37: 65–69PubMedGoogle Scholar
  54. 54.
    Felsenstein D, D'Amico DJ, Hirsch MS, Neumeyer BS, Cedenberg DH, Miranda P de Schooley RT (1985) Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl] guanine. Ann Intern Med 103: 377–380PubMedGoogle Scholar
  55. 55.
    Foucar E, Mukai KM, Foucar K, Sutherland DER, Buren CT van (1981) Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol 76: 788–801PubMedGoogle Scholar
  56. 56.
    Franzin G, Muolo A, Griminelli T (1981) Cytomegalovirus inclusions in the gastro-duodenal mucosa of patients after renal transplantation. Gut 22: 698–701PubMedGoogle Scholar
  57. 57.
    Fryd DS, Peterson PK, Ferguson RM, Simmons RL, Balfour HH, Najarian JS (1980) Cytomegalovirus as a risk factor in renal transplantation. Transplantation 30: 436–439PubMedGoogle Scholar
  58. 58.
    Funjinami RS, Nelson JA, Walker L, Oldstone MBA (1988) Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DRß chain: a means for graft rejection and immunosuppression. J Virol 62: 100–105Google Scholar
  59. 59.
    Gaston JSH, Waer M (1985) Virus-specific MHC-restricted T lymphocytes may initiate allograft rejection. Immunol Today 8: 237–239CrossRefGoogle Scholar
  60. 60.
    Gleaves CA, Smith TF, Shuster EA, Pearson GR (1985) Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 21: 217–221PubMedGoogle Scholar
  61. 61.
    Glenn J (1981) Cytomegalovirus infection following renal transplantation. Rev Infect Dis 3: 1151–1178PubMedGoogle Scholar
  62. 62.
    Gnann JW Jr, Ahlnen J, Svalander C, Olding L, Oldstone MBA, Nelson J (1988) Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol 132: 239–248PubMedGoogle Scholar
  63. 63.
    Gold E, Nankervis GA (1982) Cytomegalovirus. In: Evan AS (ed) Viral infections of humans, epidemiology and control, 2nd edn Plenum Press, New York London, pp 167–186Google Scholar
  64. 64.
    Greene MI, Fields BN (1988) Host response to viruses. In: Samter M, Talmage DW, Frank M, Austen KF, Claman HN (eds) Immunological diseases, vol 1, 4th edn. Little, Brown and Co, Boston Toronto, pp 899–921Google Scholar
  65. 65.
    Griffiths PD, Stirk PR, Ganczakowski M, Panjwani DD, Ball HG, Blacklock HA, Prentice HG (1984) Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet II: 1242–1244CrossRefGoogle Scholar
  66. 66.
    Grundy JE, Mackenzie JS, Stanley NF (1981) Influence of H2 and non-H2-genes on resistance to murine-cytomegalovirus infection. Infect Immun 32: 277–286PubMedGoogle Scholar
  67. 67.
    Grundy JE, McKeating JA, Ward PJ, Sanderson AR, Griffiths PD (1987) β2-microglobulin enhances the infectivity of cytomegalovirus, and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J Gen Virol 68: 793–803PubMedGoogle Scholar
  68. 68.
    Grundy JE, Shanley JD, Griffiths PD (1987) Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet II: 996–999CrossRefGoogle Scholar
  69. 69.
    Grundy JE, Super M, Lui S, Sweny P, Griffiths PD (1987) The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney. Transplant Proc 19: 2126–2128PubMedGoogle Scholar
  70. 70.
    Grundy JE, Ayles HM, McKeating JA, Butcher RG, Griffiths PD, Poulter LW (1988) Enhancement of class I HLA antigen expression by cytomegalovirus infection: role in amplification of the virus. J Med Virol 25: 483–495PubMedGoogle Scholar
  71. 71.
    Grundy JE, Lui SF, Super M, Berry NJ, Sweny P, Fernando ON, Moorhead J, Griffiths PD (1988) Symptomatic cytomegalovirus infection in seropositive recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 11: 132–135CrossRefGoogle Scholar
  72. 72.
    Hackman RC, Myerson D Meyers JD, Shulman HM, Sale GE, Goldstein LC, Rastetter M, Flournoy N, Thomas ED (1985) Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody. J Infect Dis 151: 325–329PubMedGoogle Scholar
  73. 73.
    Hall BM, Bishop GA, Duggin GG, Horvatti JS, Philips J, Tiller PJ (1984) Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet II: 247–251CrossRefGoogle Scholar
  74. 74.
    Hamilton JD (1982) Cytomegalovirus and immunity. In: Melnick JL (ed) Monographs in virology, vol 12. Karger, Basel New YorkGoogle Scholar
  75. 75.
    Harbison MA, De Girolami PC, Jenkins RL, Hammer SM (1988) Ganciclovir therapy of severe cytomegalovirus infection in solid-organ transplant recipients. Transplantation 46: 82–88PubMedGoogle Scholar
  76. 76.
    Hart IK, Kennedy PGE (1988) Guillain-Barré syndrome associated with cytomegalovirus infection. Q J Med [New Ser 67] 253: 425–430Google Scholar
  77. 77.
    Hecht DW, Snydman DR, Crumpacker CS, Barbara GW, Heinze-Lacey B (1988) Ganciclovir for treatment of renal transplant associated primary cytomegalovirus pneumonia. J Infect Dis 157: 187–188PubMedGoogle Scholar
  78. 78.
    Heieren MH, Woude FJ van der, Balfour HH (1988) Cytomegalovirus replicates efficiency in human kidney mesangial cells. Proc Natl Acad Sci USA 85: 1642–1646PubMedGoogle Scholar
  79. 79.
    Herrera GA, Alexander RW, Cooley CF, Luke RG, Kelly DR, Curtis JJ, Gockerman JP (1986) Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int 29: 725–733PubMedGoogle Scholar
  80. 80.
    Hirsch M, Schooley RT, Cosimi AB, Russell PS, Delmonico FL, Tolkoff-Rubin NE, Herrin JT, Cantell K, Farrell M, Rota TR, Rubin RH (1983) Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal transplant recipients. N Engl J Med 308: 1489–1493PubMedCrossRefGoogle Scholar
  81. 81.
    Ho M (1982) Cytomegalovirus, biology and infection. Plenum Press, New York London, pp 3–213Google Scholar
  82. 82.
    Ho M, Suwansirikul S, Dowling JN (1975) The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 293: 1109–1112PubMedCrossRefGoogle Scholar
  83. 83.
    Howard RJ, Najarian JS (1974) Cytomegalovirus-induced immunosuppression. Clin Exp Immunol 18: 109–118PubMedGoogle Scholar
  84. 84.
    Janssen HP, Loon AM van, Meddens HJM, Eickman-Josten ECM, Hoitsma AJ, Witte TJM de, Quint WGV (1988) Immunological detection of cytomegalovirus early antigen on monolayers inoculated with urine specimens by centrifugation and cultured for 6 days as alternative to conventional virus isolation. J Clin Microbiol 26: 1313–1315PubMedGoogle Scholar
  85. 85.
    Jesionek A, Kiolemenoglou B (1904) Ueber einem Befund von protozöen-artigen Gebilden in den Organen einen hereditairluetischen Fötus. Münch Med Wochenschr 51: 1905–1907Google Scholar
  86. 86.
    Jiwa NM, Gemert GW van, Raap AK, Rijke FM van de, Mulder A, Lens PF, Salimans MMM, Zwaan FE, Dorp W van, Ploeg M van der (1989) Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viraemic transplant recipients by the polymerase chain reaction. Transplantation 48: 72–76PubMedGoogle Scholar
  87. 87.
    Klintmalm G, Lönnqvist B, Öberg B, Gahrton G, Lernestedt G, Lundgren G, Ringdén O, Robert K, Wahren B, Groth C (1985) Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis 17: 157–163PubMedGoogle Scholar
  88. 88.
    Kovarik J, Mayer G, Pohanka E, Schwartz M, Traindl O, Graf H, Smolen J (1988) Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Transplantation 45: 402–405PubMedGoogle Scholar
  89. 89.
    Kramer P, Kate FWJ ten, Bijnen AB, Jeekel J, Weimar W (1984) Recombinant leukocyte interferon A induces steroid resistant acute vascular rejection episodes in renal transplant recipients. Lancet I: 989–990CrossRefGoogle Scholar
  90. 90.
    Krech UH, Jung M, Jung F (1971) Cytomegalovirus in man. Karger, Basel, pp 1–105Google Scholar
  91. 91.
    Lang DJ (1984) International forum on transfusion-transmitted CMV infections. Vox Sang 46: 387–414Google Scholar
  92. 92.
    Lang DJ, Ebert PA, Rodgers BM, Bogess HP, Rixse RS (1977) Reduction of postperfusion cytomegalovirus infections following the use of leucocyte depleted blood. Transfusion 17: 391–395PubMedCrossRefGoogle Scholar
  93. 93.
    Laskin OL, Stahl-Bayliss CM, Kalman CM, Rosecan LR (1987) Use of ganciclovir to treat serious cytomegalovirus infections with AIDS. J Infect Dis 155: 323–327PubMedGoogle Scholar
  94. 94.
    Lehot JJ, Page Y, Xuan BB, Tardy JC, Chomel JJ, Girbert R, Bosshard S (1983) Severe acute pneumonia associated with cytomegalovirus. Infection 11: 175–176PubMedCrossRefGoogle Scholar
  95. 95.
    Levin MJ (1988) Antiviral therapy of herpes virus infection in renal transplant recipients. Transplant Proc 20 [Suppl 8]: 19–23PubMedGoogle Scholar
  96. 96.
    Lewis RM, Johnson PC, Golden D, Buren CT van, Kerman RH, Kahan BD (1988) The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporin-prednisolone treated renal allograft recipients. Transplantation 45: 353–359PubMedGoogle Scholar
  97. 97.
    Linnemann CC Jr, Dunn CR, First MR, Alvira M, Schiff GM (1978) Late onset of fatal cytomegalovirus infection after renal transplantation: primary or reactivation infection? Arch Intern Med 138: 1247–1250PubMedCrossRefGoogle Scholar
  98. 98.
    Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA (1974) Association of renal allograft rejection with virus infections. Am J Med 56: 280–289PubMedCrossRefGoogle Scholar
  99. 99.
    Löwenstein C (1907) Ueber protozoen-artigen Gebilde in den Organen von Kindern. Zentralbl Allg Pathol 18: 513–518Google Scholar
  100. 100.
    Luby JP, Shasby DM (1972) A sex-difference in the prevalence of antibodies to cytomegalovirus. JAMA 222: 1290–1291PubMedCrossRefGoogle Scholar
  101. 101.
    Marker SC, Howard RJ, Groth KE, Mastri AR, Simmons RL, Balfour HH (1980) A trial of vidarabine for cytomegalovirus in renal transplant patients. Arch Intern Med 140: 1441–1444PubMedCrossRefGoogle Scholar
  102. 102.
    Marker SC, Howard RJ, Simmons RL, Kalis JM, Connely DP, Najarian JS, Balfour HH Jr (1981) Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. Surgery 89: 660–671PubMedGoogle Scholar
  103. 103.
    Martin WJ, Smith TF (1986) Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol 23: 1006–1008PubMedGoogle Scholar
  104. 104.
    McKeating JA, Stagno S, Stirk PR, Griffiths PD (1985) Detection of cytomegalovirus in urine samples by enzyme-linked-immunosorbent assay. J Med Virol 16: 367–373PubMedGoogle Scholar
  105. 105.
    Merritt JC, Callender CO (1978) Adult cytomegalic inclusion retinitis. Ann Ophthalmol 10: 1059–1063PubMedGoogle Scholar
  106. 106.
    Metselaar HJ, Ploeg RJ, Loon AM van, Weiland HT, Rothbard PH, Paul LC, Brand A, Schaafsma R, Hendriks GFJ, Jeekel J, Weimar W (1988) Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors. Scand J Infect Dis 20: 135–139PubMedGoogle Scholar
  107. 107.
    Meyers JD, McGuffin RW, Bryson YJ, Cantell K, Thomas ED (1982) Treatment of cytomegalovirus-pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 146: 80–84PubMedGoogle Scholar
  108. 108.
    Meyers JD, Reed EC, Shepp DH, Thornquist M, Danliker PS, Vicary CA, Flournoy N, Kirk LE, Kersey JH, Thomas ED, Balfour HH Jr (1988) Acyclovir for prevention of cytomegalovirus infection and disease after allogenic marrow transplantation. N Engl J Med 318: 70–75PubMedCrossRefGoogle Scholar
  109. 109.
    Middeldorp JM (1985) Diagnostic and immunological aspects of the antibody response to human cytomegalovirus infection. Thesis, University of Groningen, GroningenGoogle Scholar
  110. 110.
    Middeldorp JM, Jongsma J, Haar A ter, Schirm J, The TH (1984) Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigen by enzyme-linked immunosorbent assay. J Clin Microbiol 20: 763–771PubMedGoogle Scholar
  111. 111.
    Minars N, Silverman JF, Escobar MR, Martinez AJ (1977) Fatal cytomegalic inclusion disease. Arch Dermatol 113: 1569–1571PubMedCrossRefGoogle Scholar
  112. 112.
    Mintz L, Miner RC, Yeager AS (1980) Anticomplement immunofluorescence test that used isolated fibroblast nuclei for detection of antibodies to human cytomegalovirus. J Clin Microbiol 12: 562–566PubMedGoogle Scholar
  113. 113.
    Mitchell CD, Burns W, Santos G, Saral G, Wittek A, Rook A, Manischewitz J, Quinnan G (1986) Improved immune-responses to cytomegalovirus infections in cyclosporine A versus cytoxan treated bone marrow transplant recipients. Clin Res 34: 677Google Scholar
  114. 114.
    Murray HW, Knox DL, Green WR, Susel RM (1977) Cytomegalovirus retinitis in adults. Am J Med 63: 574–584PubMedCrossRefGoogle Scholar
  115. 115.
    Myerson D, Hackman RC, Meyers JD (1984) Diagnosis of cytomegaloviral pneumonia by in situ hybridization. J Infect Dis 150: 272–277PubMedGoogle Scholar
  116. 116.
    Najarian JS, Fryd DS, Strand M, Canafox DM, Ascher NL, Payne WD, Simmons RL, Sutherland DER (1985) A single institution, randomized, prospective trial of cyclosporine versus azathioprine—antilymphocyte-globulin for immunosuppression in renal allografts. Ann Surg 201: 142–157PubMedGoogle Scholar
  117. 117.
    Napel CHH ten, Houthoff HJ, The TH (1984) Cytomegalovirus hepatitis in normal and immune-compromised hosts. Liver 4: 184–194PubMedGoogle Scholar
  118. 118.
    Neiman PE, Reeves W, Ray, G, Flournoy N, Lerner KG, Sale GE, Thomas ED (1977) A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogenic bone marrow grafts. J Infect Dis 136: 754–767PubMedGoogle Scholar
  119. 119.
    Oh CS, Stratta RJ, Fox BC, Sollinger HW, Belzer FO, Maki D (1988) Increased infections associated with the use of OKT3 for the treatment of steroid-resistant rejection in renal transplantation. Transplantation 45: 68–73PubMedGoogle Scholar
  120. 120.
    Olding LB, Jensen FC, Oldstone MBA (1975) Pathogenesis of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med 141: 561–572PubMedCrossRefGoogle Scholar
  121. 121.
    Onorato IM, Morens DM, Martone WJ, Stansfield SK (1985) Epidemiology of cytomegalovirus infections: recommendations for prevention and control. Rev Infect Dis 7: 479–497PubMedGoogle Scholar
  122. 122.
    Ozawa T, Stewart JA (1979) Immune-complex glomerulonephritis associated with cytomegalovirus infection. Am J Clin Pathol 72: 103–107PubMedGoogle Scholar
  123. 123.
    Pass RF, Whitley RJ, Diethelm AG, Whelchel JD, Reynolds DW, Alford CA (1980) Cytomegalovirus infection in patients with renal transplants: potentiation by anti-thymocyte-globulin and incompatible graft. J Infect Dis 142: 9–17PubMedGoogle Scholar
  124. 124.
    Pass RF, Griffiths PD, August AM (1983) Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis 147: 40–46PubMedGoogle Scholar
  125. 125.
    Paya CV, Hermans PE, Smith TF, Rakela J, Wiesner RH, Krom RAF, Torres VE, Sterioff S, Wilkowske CJ (1988) Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation 46: 229–234PubMedGoogle Scholar
  126. 126.
    Peterson PK, Balfour HH, Marker SC, Fryd DS, Howard RJ, Simmons RL (1980) Cytomegalovirus-disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 59: 283–300PubMedGoogle Scholar
  127. 127.
    Peterson PK, Balfour HH, Fryd S, Ferguson R, Kronenberg R, Simmons RL (1983) Risk factors in the development of cytomegalovirus-related pneumonia in renal transplant recipients. J Infect Dis 148: 1121PubMedGoogle Scholar
  128. 128.
    Phipps PH, Grégoire L, Rossier E, Perry E (1983) Comparison of five methods of antibodies to human cytomegalovirus. J Clin Microbiol 18: 1296–1300PubMedGoogle Scholar
  129. 129.
    Plotkin, SA, Farquhar J, Hornberger E (1976) Clinical trials of immunization with the Town 125 strain of human cytomegalovirus. J Infect Dis 134: 470–475PubMedGoogle Scholar
  130. 130.
    Plotkin SA, Starr SE, Brian CK (1982) In vitro and in vivo responses of cytomegalovirus to acyclovir. Am J Med 73: 257–261PubMedGoogle Scholar
  131. 131.
    Plotkin SA, Friedman HM, Fleisher GR, Dafoe DC, Grossmann RA, Smiley ML, Starr SE, Wlodaver C, Friedman AD, Barker CF (1984) Town-vaccine induced prevention of cytomegalovirus disease after renal transplantation. Lancet I: 528–530CrossRefGoogle Scholar
  132. 132.
    Plotkin SA, Drew WL, Felsenstein D, Hirsch MS (1985) Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-proxymethyl)guanine. J Infect Dis 152: 833–834PubMedGoogle Scholar
  133. 133.
    Quinnan GV Jr, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH (1982) Cytotoxic T cells in cytomegalovirus infection: HLA restricted T-lymphocyte and non T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus in bone-marrow-transplant recipients. N Engl J Med 307: 6–13CrossRefGoogle Scholar
  134. 134.
    Ramsey PG, Fife KH, Hackman C, Meyers JD, Corey L (1982) Herpes simplex virus pneumonia. Ann Intern Med 97: 813–820PubMedGoogle Scholar
  135. 135.
    Ravin CE, Walker-Smith G, Ahern MJ, McLoud T, Putman C, Milchgrub S (1977) Cytomegaloviral infection presenting as a solitary pulmonary nodule. Chest 71:220–222PubMedGoogle Scholar
  136. 136.
    Reed EC, Danliker PS, Meyers JD (1986) Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high dose corticosteroids. Ann Intern Med 105: 214–215PubMedGoogle Scholar
  137. 137.
    Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, Rubin RH (1981) Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 305: 57–63PubMedCrossRefGoogle Scholar
  138. 138.
    Ringdén O, Lönnqvist B, Paulin T, Ahlmen J, Klintmalm G, Wahren B, Lernestedt JO (1986) Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J Antimicrob Chemother 17: 373–387PubMedGoogle Scholar
  139. 139.
    Roenhorst HW, Beelen JM, Middeldorp JM, Schirm J, Tegzess AM, The TH (1985) Maintenance of CMV latency and host immune responses of long term renal allograft survivors. Clin Exp Immunol 61: 72–79PubMedGoogle Scholar
  140. 140.
    Roenhorst HW, Tegzess AM, Beelen JM, Middeldorp JM, The TH (1985) HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal transplantation. Br Med J 291: 619–622CrossRefGoogle Scholar
  141. 141.
    Rook AH (1988) Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 10 [Suppl 3]: 460–467Google Scholar
  142. 142.
    Rook AH, Quinnan GV Jr, Frederik W Jr, Manischewitz JF, Kirmani N, Dantzler T, Lee BB, Currier CB Jr (1984) Importance of cytotoxic lymphocytes during cytomegalovirus-infection of renal transplant recipients. Am J Med 76: 385–392PubMedCrossRefGoogle Scholar
  143. 143.
    Rosen P, Armstrong D, Rice N (1973) Gastrointestinal cytomegalovirus infection. Arch Intern Med 132: 274–276PubMedCrossRefGoogle Scholar
  144. 144.
    Rubin RH (1988) Infection in the renal and liver transplant patient in the compromised host. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 2nd edn. Plenum Press, New York London, pp 569–583Google Scholar
  145. 145.
    Rubin RH, Colvin RB (1986) Cytomegalovirus infection in renal transplantation: clinical importance and control. In: Williams GM, Burdick JF, Solez K (eds) Kidney transplant rejection. Diagnosis and Treatment. Dekker, New York Basel, pp 283–304Google Scholar
  146. 146.
    Rubin RH, Cosimi AB, Tolkoff-Rubin NE, Russell PS, Hirsch MS (1977) Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 24: 458–464PubMedGoogle Scholar
  147. 147.
    Rubin RH, Russell PS, Levin M, Cohen C (1979) Summary of a workshop on cytomegalovirus infection during organ transplantation. J Infect Dis 139: 728–734PubMedGoogle Scholar
  148. 148.
    Rubin RH, Cosimi AB, Hirsch MS, Herrin JT, Russell PS, Tolkoff-Rubin NE (1981) Effects of antithymocyte globulin on cytomegalovirus infection in normal transplant recipients. Transplantation 31: 143–145PubMedGoogle Scholar
  149. 149.
    Rubin RH, Tolkoff-Rubin NE, Oliver D, Rota TR, Hamilton J, Betts RF, Pass RF, Hillis W, Szmuness W, Farell ML, Hirsch MS (1985) Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40: 243–249PubMedGoogle Scholar
  150. 150.
    Rubin RH, Wilson EJ, Barrett LV, Medearis DN (1986) The protective effects of hyperimmune anti-murine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunization. Clin Immunol Immunopathol 39: 151–158PubMedCrossRefGoogle Scholar
  151. 151.
    Schirm J, Timmerije W, Bij W van der, The TH, Wilterdink JB, Tegzess AM, Son WJ van, Schröder FP (1987) Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies. J Med Virol 23: 31–40PubMedGoogle Scholar
  152. 152.
    Schooley RT, Hirsch MS, Colvin RB, Cosimi B, Tolkoff-Rubin NE, McCluskey RT, Burton RC, Russell PS, Herrin JT, Delmonico FL, Giorgi JV, Henle W, Rubin RH (1983) Association of herpes-infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med 308: 307–313PubMedCrossRefGoogle Scholar
  153. 153.
    Schuster V, Matz B, Wiegand H, Traub B, Kampa D, Neumann-Haefelin D (1986) Detection of human cytomegalovirus in urine by DNA-DNA and RNA-DNA hybridization. J Infect Dis 154: 309–314PubMedGoogle Scholar
  154. 154.
    Shanley JD, Pesanti EL, Nugent KM (1982) The pathogenesis of pneumonitis due to murine cytomegalovirus. J Infect Dis 146: 388–396PubMedGoogle Scholar
  155. 155.
    Shepp DH, Danliker PS, Miranda P de, Burnette TC, Cederberg DM, Kirk E, Meyers JD (1985) Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethyxomethyl]guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med 103: 368–373PubMedGoogle Scholar
  156. 156.
    Shorr RI, Longo WL, Oberley TD, Bozdeck MJ, Walker DL (1987) Cytomegalovirus-associated tubulointerstitial nephritis in an allogenic bone-marrow-transplant recipient. Ann Intern Med 107: 351–352PubMedGoogle Scholar
  157. 157.
    Simmons RL, Weil R, Tallent MB, Kjellstrand CM, Najarian JS (1970) Do mild infections trigger the rejection of renal allografts. Transplant Proc 3: 419–423Google Scholar
  158. 158.
    Simmons RL, Lopez C, Balfour HH Jr, Kalis J, Ratazzi LC, Najarian JS (1974) Cytomegalovirus: clinical, virological correlations in renal transplant recipients. Ann Surg 180: 623–634PubMedGoogle Scholar
  159. 159.
    Simmons RL, Matas AJ, Ratazzi LC, Balfour HH Jr, Howard RJ, Najarian JS (1977) Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 82: 537–546PubMedGoogle Scholar
  160. 160.
    Smiley ML, Wlodavir CG, Grossmann RA, Barker CF, Perloff LJ, Tustin NB, Starr SE, Plotkin SA, Friedman HM (1985) The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 40: 157–161PubMedGoogle Scholar
  161. 161.
    Smith MG (1954) Propagation of salivary gland virus of the mouse in tissue culture. Proc Soc Exp Biol Med 86: 435–440PubMedGoogle Scholar
  162. 162.
    Smith RD, Wehner RW (1980) Acute cytomegalovirus nephritis: an experimental model. Lab Invest 43: 278–286PubMedGoogle Scholar
  163. 163.
    Snydman DR (1988) Ganciclovir for cytomegalovirus-disease associated with renal transplants. Rev Infect Dis 10 [Suppl 3]: 554–562Google Scholar
  164. 164.
    Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Levey AS, Strom TB, Carpenter LB, Levey RH, Harmon WE, Zimmerman CE, Shapiro ME, Steinman T, LoGerfo F, Idelson B, Schröter PJ, Levin MJ, McIver J, Leszczynski J, Grady GF (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317: 1049–1054PubMedCrossRefGoogle Scholar
  165. 165.
    Snydman DR, Werner BG, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS, Strom TB, Carpenter CB, Berardi VP, Levey RH, Harmon WE, Zimmerman CE, Tenny A, Heinze-Lacey B, Shapiro ME, Steinman T, LoGerfo F, Idelson B, McIver J, Leszczynski J, Grady GF (1988) Further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immunoglobulin: interim comparison of a randomized and an open-label trial. Transplant Proc 20 [Suppl 8]: 24–30PubMedGoogle Scholar
  166. 166.
    Sommadossi J, Bevan R, Ling T, Lee F, Mastre B, Chaplin MD, Nerenberg C, Koretz S, Buhles WC Jr (1988) Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function. Rev Infect Dis 10 [Suppl 3]: 507–514Google Scholar
  167. 167.
    Son WJ van, Jagt EJ van der, Woude FJ van der, Slooff MJH, Meijer S, The TH, Tegzess AM, Slikke LB van der, Donker AJM (1984) Pneumatosis intestinalis in patients after cadaveric kidney transplantation: possible relationship with an active cytomegalovirus infection. Transplantation 38: 506–510PubMedCrossRefGoogle Scholar
  168. 168.
    Son WJ van, Woude FJ van der, Hem GK van der, The TH, Ockhuizen T, Tegzess AM (1985) Complement activation associated with active cytomegalovirus infection in renal transplant patients, and its absence in transplant rejection episodes. Transplantation 39: 510–514PubMedGoogle Scholar
  169. 169.
    Son WJ van, Peset R, Duipmans JC, Mark TW van der, The TH, Tegzess AM (1987) Cytomegalovirus infection after renal transplantation: pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide (KCO) in patients with symptomatic and asymptomatic infection. Transplantation 44: 149–150PubMedGoogle Scholar
  170. 170.
    Son WJ van, Tegzess AM, The TH, Duipmans JC, Sloff MJH, Mark TW van der, Peset R (1987) Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation, even in asymptomatic patients: possible relationship with complement activation. Am Rev Respir Dis 136: 580–585PubMedGoogle Scholar
  171. 171.
    Son WJ van, Bij W van der, Tegzess AM, Anema J, Giessen M van der, Hem GK van der, Marrink JM, The TH (1989) Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation? Clin Immunol Immunopathol 50: 109–121PubMedCrossRefGoogle Scholar
  172. 172.
    Son WJ van, Wij W van der, The TH, Peset R, Mark TW van der, Tegzess AM (1989) Evidence for pulmonary dysfunction in all patients with symptomatic and asymptomatic cytomegalovirus (CMV) infection after renal transplantation. Transplant Proc 21: 2065–2068PubMedGoogle Scholar
  173. 173.
    Spector SA, Rua JA, Spector DH, McMillan R (1984) Detection of human cytomegalovirus in clinical specimens by DNA-DNA hybridization. J Infect Dis 150: 121–126PubMedGoogle Scholar
  174. 174.
    Stagno S, Volanakis J, Reynolds DW, Stroud R, Alford CA (1977) Immune-complexes in congenital and natal cytomegalovirus infections in man. J Clin Invest 60: 838–845PubMedCrossRefGoogle Scholar
  175. 175.
    Stagno S, Pass RF, Reynolds DW, Alford CA (1981) Diagnosis of cytomegalovirus infections. In: Nahmias AJ, Dowdle WR, Schinazi RF (eds) The human herpes viruses, an interdisciplinary perspective. Elsevier, New York Oxford, pp 363–373Google Scholar
  176. 176.
    Stimler NP, Bloor CM, Hugli TE (1983) Immunopharmacology of complement anaphylatoxins in the lung. In: Newball HH (ed) Immunopharmacology of the lung. Dekker, New York, pp 401–434Google Scholar
  177. 177.
    Stirk PR, Griffiths PD (1987) Use of monoclonal antibodies for the diagnosis of cytomegalovirus infection by the detection of early antigen fluorescent foci (DEAFF) in cell culture. J Med Virol 21: 324–337Google Scholar
  178. 178.
    Stoffel M, Gianello P, Squifflet JP, Pirson Y, Alexandre GPJ (1988) Effects of 9-(2-hydroxy-1-[hydroxymethyl]-ethoxymethyl)guanine (DHPG) on cytomegalovirus pneumonitis after renal transplantation. Transplantation 46: 594–595PubMedGoogle Scholar
  179. 179.
    Suwansirikul S, Rao N, Dowling JN, Ho M (1977) Primary and secondary cytomegalovirus infection: clinical manifestation after renal transplantation. Arch Intern Med 137: 1026–1029PubMedCrossRefGoogle Scholar
  180. 180.
    Tabak MA, Jordan SC, Ettenger RB, Sakai R, Dupuis MA, Fine RN (1985) Diagnosis of cytomegalovirus infection posttransplantation via fine needle aspiration biopsy. Transplant Proc 17: 153Google Scholar
  181. 181.
    Tamura T, Chiba S, Chiba Y, Nakao T (1980) Virus excretion and neutralizing antibody response in saliva in human cytomegalovirus infection. Infect Immun 29: 842–845PubMedGoogle Scholar
  182. 182.
    The TH, Klein G, Langenhuysen MMAC (1974) Antibody reactions to virus specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. Clin Exp Immunol 16: 1–12Google Scholar
  183. 183.
    The TH, Bij W van der, Berg AP van den, Giessen M van der, Weits J, Sprenger HG, Son WJ van (1989) Cytomegalovirus-antigenemia. Rev Infect Dis (in press)Google Scholar
  184. 184.
    Till GO, Johnson KJ, Kunkel R, Ward PA (1982) Intravascular activation of complement and acute lung injury. J Clin Invest 69: 1126–1135PubMedGoogle Scholar
  185. 185.
    Tolkoff-Rubin NE, Rubin RH, Keller E, Baker GP, Stewart JA, Hirsch MS (1978) Cytomegalovirus infections in dialysis patients and personnel. Ann Intern Med 89: 625–628PubMedGoogle Scholar
  186. 186.
    Tsuji Nose Y, Inouye Komeri K, Yumamura M (1981) HLA-D/DR linked immune response to candida allergen: an in vivo and in vitro study in Japanese. Tokai J Exp Clin Med 6: 113–120Google Scholar
  187. 187.
    Volpi AV, Whitley RJ, Ceballos R, Stagno S (1983) Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis 147: 1119–1120PubMedGoogle Scholar
  188. 188.
    Wade JC, Hintz M, McGuffin RW, Springmeyer SC, Connor JD, Meyers JD (1982) Treatment of cytomegalovirus pneumonia with high dose acyclovir. Am J Med 73: 249–256PubMedGoogle Scholar
  189. 189.
    Waner JL, Weller TH, Kevy SV (1973) Patterns of cytomega-loviral complement-fixing antibody reactivity: a longitudinal study of blood donors. J Infect Dis 127: 538–543PubMedGoogle Scholar
  190. 190.
    Wehner RW, Smith RD (1983) Progressive cytomegalovirus glomerulonephritis: an experimental model. Am J Pathol 112: 313–325PubMedGoogle Scholar
  191. 191.
    Weir MR, Irwin BC, Maters AW, Genemans G, Shen SY, Charache P, Williams GM (1987) Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity. Transplantation 43: 187–192PubMedGoogle Scholar
  192. 192.
    Weir MR, Irwin BC, Maters AW, Genemans G, Shen SY, Charache P, Williams GM (1987) Morbid outcome of cytomegalovirus-negative transplant recipients receiving cytomegalovirus-positive kidneys. Transplant Proc 19: 2137–2141PubMedGoogle Scholar
  193. 193.
    Weir MR, Henry ML, Blackmore M, Smith J, First MR, Irwin B, Shen S, Genemans G, Alexandre JW, Corry RJ, Nghiem DH, Ferguson RM, Kittur D, Shield CF, Sommer BG, Williams GM (1988) Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. Transplantation 45: 111–116PubMedGoogle Scholar
  194. 194.
    Weller TH (1970) Cytomegalovirus: the difficult years. J Infect Dis 122: 532–539PubMedGoogle Scholar
  195. 195.
    Weller TH, Hanshaw JB, Scott DE (1960) Serological differentiation of viruses responsible for cytomegalic inclusion disease. Virology 12: 130–132PubMedCrossRefGoogle Scholar
  196. 196.
    Wertheim P, Buurman C, Geelen J, Noordaa J van der (1983) Transmission of cytomegalovirus by renal allograft demonstrated by restriction enzyme analysis. Lancet I: 980–981CrossRefGoogle Scholar
  197. 197.
    Whitley RJ (1988) Ganclclovir — have we established clinical value in the treatment of cytomegalovirus infections? Ann Intern Med 108: 452–454PubMedGoogle Scholar
  198. 198.
    Willebrand E von, Pettersson E, Ahonen J, Häyry P (1986) CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 42: 364–367Google Scholar
  199. 199.
    Williams PF, Wreghitt T, Joysey V, Evans DB, Calne RY (1988) Cytomegalovirus matching in renal transplantation. Lancet II: 569CrossRefGoogle Scholar
  200. 200.
    Wink K, Schmitz H (1980) Cytomegalovirus myocarditis. Am Heart J 100: 667–672PubMedCrossRefGoogle Scholar
  201. 201.
    Winston DJ, Ho WG, Lin CH, Bartoni K, Budinger MD, Gale RP, Champlin RE (1987) Intravenous immunoglobulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 106: 12–18PubMedGoogle Scholar
  202. 202.
    Winston DJ, Ho WG, Bartoni K, Holland GN, Mitsuyasu RT, Busuttil RW, Champlin RE (1988) Ganciclovir therapy for cytomegalovirus infection in recipients of bone-marrow transplants and other immunosuppressed patients. Rev Infect Dis 10 [Suppl 3]: 547–553Google Scholar
  203. 203.
    Wu BC, Dowling JN, Armstrong JA, Ho M (1975) Enhancement of mouse cytomegalovirus infection during host-versusgraft reaction. Science 190: 56–58PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • W. J. van Son
    • 1
  • T. H. The
    • 2
  1. 1.Department of Internal Medicine, Division of Renal TransplantationUniversity Hospital GroningenGroningenThe Netherlands
  2. 2.Division of Clinical ImmunologyUniversity Hospital GroningenGroningenThe Netherlands

Personalised recommendations